Pandemic Vaccines: How Are We Going to Be Better Prepared Next Time?

被引：10

作者：

Krammer, Florian ^{[1
]}

机构：

[1] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA

来源：

MED | 2020年 / 1卷 / 01期

关键词：

IMMUNOGENICITY;

D O I：

10.1016/j.medj.2020.11.004

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

In response to the SARS-CoV-2 pandemic, we are currently witnessing the fastest vaccine development in history. While these vaccines will now make a significant impact on ending the pandemic, they were needed much earlier. Here I discuss how to ensure that vaccines will become available within 3-4 months after a new outbreak.

引用

页码：28 / +

页数：6

共 15 条

[1] The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Gorbalenya, Alexander E.
Baker, Susan C.
Baric, Ralph S.
de Groot, Raoul J.
Drosten, Christian
Gulyaeva, Anastasia A.
Haagmans, Bart L.
Lauber, Chris
Leontovich, Andrey M.
Neuman, Benjamin W.
Penzar, Dmitry
Perlman, Stanley
Poon, Leo L. M.
Samborskiy, Dmitry V.
Sidorov, Igor A.
Sola, Isabel
Ziebuhr, John
[J]. NATURE MICROBIOLOGY, 2020, 5 (04) : 536 - 544
[2] Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013
Hemida, M. G.
Perera, R. A.
Wang, P.
Alhammadi, M. A.
Siu, L. Y.
Li, M.
Poon, L. L.
Saif, L.
Alnaeem, A.
Peiris, M.
[J]. EUROSURVEILLANCE, 2013, 18 (50): : 21 - 27
[3] Huang Angkana T, 2020, medRxiv, DOI [10.1038/s41467-020-18450-4, 10.1101/2020.04.14.20065771]
[4] An mRNA Vaccine against SARS-CoV-2-Preliminary Report
Jackson, L. A.
Anderson, E. J.
Rouphael, N. G.
Roberts, P. C.
Makhene, M.
Coler, R. N.
McCullough, M. P.
Chappell, J. D.
Denison, M. R.
Stevens, L. J.
Pruijssers, A. J.
McDermott, A.
Flach, B.
Doria-Rose, N. A.
Corbett, K. S.
Morabito, K. M.
O'Dell, S.
Schmidt, S. D.
Swanson, P. A.
Padilla, M.
Mascola, J. R.
Neuzil, K. M.
Bennett, H.
Sun, W.
Peters, E.
Makowski, M.
Albert, J.
Cross, K.
Buchanan, W.
Pikaart-Tautges, R.
Ledgerwood, J. E.
Graham, B. S.
Beigel, J. H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) : 1920 - 1931
[5] SARS-CoV-2 vaccines in development
Krammer, Florian
[J]. NATURE, 2020, 586 (7830) : 516 - 527
[6] Latinne Alice, 2020, bioRxiv, DOI [10.1038/s41467-020-17687-3, 10.1101/2020.05.31.116061]
[7] Lin JT, 2007, ANTIVIR THER, V12, P1107
[8] A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Martin, Julie E.
Louder, Mark K.
Holman, LaSonji A.
Gordon, Ingelise J.
Enama, Mary E.
Larkin, Brenda D.
Andrews, Charla A.
Vogel, Leatrice
Koup, Richard A.
Roederer, Mario
Bailer, Robert T.
Gomez, Phillip L.
Nason, Martha
Mascola, John R.
Nabel, Gary J.
Graham, Barney S.
[J]. VACCINE, 2008, 26 (50) : 6338 - 6343
[9] Origins of the 2009 H1N1 influenza pandemic in swine in Mexico
Mena, Ignacio
Nelson, Martha I.
Quezada-Monroy, Francisco
Dutta, Jayeeta
Cortes-Fernandez, Refugio
Horacio Lara-Puente, J.
Castro-Peralta, Felipa
Cunha, Luis F.
Trovao, Nidia S.
Lozano-Dubernard, Bernardo
Rambaut, Andrew
van Bakel, Harm
Garcia-Sastre, Adolfo
[J]. ELIFE, 2016, 5
[10] SARS-like WIV1-CoV poised for human emergence
Menachery, Vineet D.
Yount, Boyd L., Jr.
Sims, Amy C.
Debbink, Kari
Agnihothram, Sudhakar S.
Gralinski, Lisa E.
Graham, Rachel L.
Scobey, Trevor
Plante, Jessica A.
Royal, Scott R.
Swanstrom, Jesica
Sheahan, Timothy P.
Pickles, Raymond J.
Corti, Davide
Randell, Scott H.
Lanzavecchia, Antonio
Marasco, Wayne A.
Baric, Ralph S.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (11) : 3048 - 3053

← 1 2 →